Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic MinoritiesSikander Ailawadhi, Abdel-Ghani Azzouqa, David Hodge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) GuidelineHumera Khurshid, Nofisat Ismaila, Jessica Bian, et al.JCO Oncology Practice|February 13, 2020
Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient CareVivek Kumar, Muhamad Alhaj-Moustafa, Leyla Bojanini, et al.Blood Cancer Journal|October 2, 2019
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemiaVivek Kumar, Sikander Ailawadhi, Leyla Bojanini, et al.British Journal of Haematology|August 7, 2018
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cellsAneel Paulus, Alak Manna, Sharoon Akhtar, et al.JCO Oncology Practice|March 21, 2022
Social Media and Professional Development for Oncology ProfessionalsAnusha Chidharla, Audun Utengen, Deanna J Attai, et al.Clinical Lung Cancer|October 25, 2023
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung CancerAakash Desai, Caleb J Smith, Yash Ashara, et al.Cancer Treatment and Research Communications|August 2, 2023
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief reportAakash Desai, Sagar Rakshit, Radhika Bansal, et al.The Oncologist|May 1, 2019
Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?Narjust Duma, Azzouqa Abdel-Ghani, Siddhartha Yadav, et al.Cancers|January 21, 2023
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple MyelomaSikander Ailawadhi, Ricardo D Parrondo, Navnita Dutta, et al.Pageof 7